Yousif Capital Management LLC Sells 1,074 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Yousif Capital Management LLC cut its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 4.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,504 shares of the company’s stock after selling 1,074 shares during the quarter. Yousif Capital Management LLC’s holdings in Pediatrix Medical Group were worth $335,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MD. Rubric Capital Management LP grew its position in shares of Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after purchasing an additional 125,000 shares in the last quarter. State Street Corp boosted its stake in Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after purchasing an additional 50,597 shares during the period. Pacer Advisors Inc. purchased a new stake in Pediatrix Medical Group during the 4th quarter valued at approximately $35,492,000. Geode Capital Management LLC raised its position in shares of Pediatrix Medical Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after buying an additional 45,155 shares during the last quarter. Finally, Weiss Asset Management LP lifted its holdings in shares of Pediatrix Medical Group by 50.5% in the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after buying an additional 306,143 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Down 2.8 %

Shares of MD stock opened at $14.06 on Tuesday. The company has a market cap of $1.21 billion, a PE ratio of -4.60, a price-to-earnings-growth ratio of 1.38 and a beta of 1.57. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $16.41. The stock’s 50 day simple moving average is $13.81 and its two-hundred day simple moving average is $12.82. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Mizuho lifted their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Deutsche Bank Aktiengesellschaft boosted their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Truist Financial cut their price target on Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating for the company in a report on Monday, January 6th. Finally, Jefferies Financial Group upped their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $16.25.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.